Hospital M&A activity caught up to pre-pandemic levels in Q2

The latest stories trending on MedCity News.

Editor's Pick

Top Story Hospital M&A Activity Caught Up to Pre-Pandemic Levels in Q2 M&A activity among hospitals and health systems increased in Q2 of 2023 — there were 20 deals in Q2 compared to 15 deals in Q1, according to a new report. This surge brought Q2's M&A activity levels in line with those observed before the pandemic. Q2's 20 deal marks the highest number of announced transactions for hospitals and health systems since Q1 of 2020. Sponsored Content Take Our Survey! How Do Consultants View The Healthcare Landscape and Employee Benefits? Presented by MedCity News Your experience positions you to be a thought leader so your participation is vital to this research. We will use the data gathered from this survey for a report exploring how the role of the consultant is evolving, in line with the needs of self-insured employers and the shifting healthcare landscape. We value your input.  Click here to take the survey.  If you complete the survey, you will be eligible for a $250 gift card.

Featured News

Ticking the Talons of Healthcare Transparency As of January 1, employer-sponsored Group Health Plans and Health Insurance Issuers must make make the prices of 500 medical services available via an Internet-based tool. The Transparency in Coverage final rule gets even tougher on January 1, 2024, when the prices of all medical services must be made available via an Internet-based tool. Report: 10 Prescription Drugs Took Up 22% of Medicare Part D Spending in 2021 KFF found that the 10 top-selling Part D drugs represented $47.7 billion of the $215.7 billion total gross Medicare Part D drug spending in 2021. Eliquis, a blood thinner by Bristol Myers Squibb, accounted for the most spending out of these 10 drugs at $12.6 billion.  Startup Tenpoint Lands $70M to Bring Vision-Restoring Cell Therapy to the Eye Tenpoint Therapeutics' name refers to the time it takes for an image to hit the retina and be processed by the brain. The regenerative medicine startup is developing cell therapies it hopes restore that vision capability for patients with degenerative eye disorders.

Resources

Sponsored Content MedCity Pivot Podcast: 2 Perspectives on how AI Can Soothe Burnout, Burden of Prior Authorization We interviewed Punit Singh Soni, CEO of Suki, who has developed an AI voice assistant to automate clinical documentation. We also interviewed Niall O' Connor, chief technology officer, Cohere Health who uses AI to streamline the burdensome process of prior authorization. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe